2022 American Transplant Congress
Low-Dose Aspirin is More Critical Than Statins in Preventing Transplant Renal Artery Stenosis
Urology, Henan Provincial People's Hospital, Zhengzhou, China
*Purpose: To explore the clinical value of low-dose aspirin (100mg) and statins (10 ~ 20mg) in the prevention of transplant renal artery stenosis (TRAS).*Methods: A…2022 American Transplant Congress
Low-Dose Aspirin is Effective in Preventing Transplant Renal Artery Stenosis: A Prospective Randomized Controlled Trial
Henan Provincial People's Hospital, Zhengzhou, Henan Province, China
*Purpose: Transplant renal artery stenosis (TRAS), the most common post-transplant vascular complication, leads to resistant hypertension, renal impairment, and even graft loss. No effective prophylactic…2022 American Transplant Congress
Domino Living Donor Kidney Transplant Following Therapeutic Nephrectomy for Renal Artery Stenosis with Arterial Reconstruction and Viability Assessment Using Ex Vivo Normothermic Perfusion: A Case Series
*Purpose: Ex vivo normothermic perfusion (EVNP) is increasingly recognized as a viability tool to increase organ utilization. We report use of EVNP to assess graft…2021 American Transplant Congress
Single Center Experience in Ex Vivo Hilar Renal Artery Aneurysm Repair and Autotransplantation
*Purpose: In this study, we review our centers experience with complex renal artery aneurysms using our preferred technique of open nephrectomy, ex vivo repair, and…2021 American Transplant Congress
Risk Factors and Outcome of Transplant Renal Artery Stenosis in Kidney Transplant Recipients – A Nested Case-control Study
*Purpose: Transplant renal artery stenosis (TRAS) is a treatable cause of renal allograft dysfunction. It presents commonly in the early post-transplant period with variable clinical…2020 American Transplant Congress
Time for Change: Assessment of Renal Transplant Artery Stenosis with N.A.T.I.V.E. True-F.I.S.P. and N.A.T.I.V.E. G.R.E
*Purpose: Non-contrast MRA can be fraught with artifact and lack of signal both in areas of stenosis as well as normal vessels. Therefore, it is…2018 American Transplant Congress
De Novo DSA against Third Party Extension Vessels Used in Kidney and Pancreas Transplantation
University of Wisconsin, Madison.
Third party ABO-compatible vessel allografts (VA) are sometimes used as extension vessels for kidney and pancreas transplants (TX). The frequency and implications of de novo…2017 American Transplant Congress
Fibromuscular Dysplasia in Living Kidney Donors: Characteristics and Recipient Outcomes.
Introduction: Presence of incidentally detected fibromuscular dysplasia (FMD) is a challenging and controversial issue for selection of living kidney donors (LKD). Whether donors with FMD…2017 American Transplant Congress
Classification of Fibromuscular Dysplasia in Kidney Donors Based on Severity and Extent of Lesion.
Introduction: Selection of living kidney donors (LKD) with renal artery (RA) fibromuscular dysplasia (FMD) is controversial, as traditional diagnostic classifications lack estimates on FMD severity.…2017 American Transplant Congress
Endovascular Management of Transplant Renal Artery Stenosis: A Safe and Effective Treatment.
Background:Transplant Renal Artery Stenosis (TRAS) is a low incidence complication, but if untreated, can lead to graft failure, refractory hypertension (HT) and reduced life expectancy.…
American Transplant Congress abstracts